Retrospective Study of Keloid Disorder

NCT ID: NCT02923596

Last Updated: 2016-10-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-09-30

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose of this retrospective study is to review and analyze the information and data that has been already been generated during the course of routine practice of medicine by the investigators from 2007 up until Sept 1, 2016 from keloid patients who have sought medical care or medical advice for their keloid disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To retrospectively review and analyze clinical data that has already been collected from keloid patients including photographs taken of keloid lesions during routine practice of medicine by the investigators 1) To better understand natural history of keloid disorder (KD), 2)To determine the ethnic incidence and prevalence of keloid, 3) To determine the rate of familial keloids, 4) To determine response to different treatment modalities, 5) To determine risk factors for development and worsening of keloid lesions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Keloid

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Ear Keloids

Records of Patients with Ear Keloids will be reviewed. Data and photographs will be analysed.

History of prior Surgery

Intervention Type PROCEDURE

History of prior Surgery will be reviewed

History of Radiation Therapy

Intervention Type RADIATION

History of prior radiation therapy will be reviewed

Patients with Neck Keloids

Records of Patients with Neck area Keloids will be reviewed. Data and photographs will be analysed.

History of prior Surgery

Intervention Type PROCEDURE

History of prior Surgery will be reviewed

History of Radiation Therapy

Intervention Type RADIATION

History of prior radiation therapy will be reviewed

Patients with Scalp Keloids

Records of Patients with Scalp Keloids will be reviewed. Data and photographs will be analysed.

History of prior Surgery

Intervention Type PROCEDURE

History of prior Surgery will be reviewed

History of Radiation Therapy

Intervention Type RADIATION

History of prior radiation therapy will be reviewed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

History of prior Surgery

History of prior Surgery will be reviewed

Intervention Type PROCEDURE

History of Radiation Therapy

History of prior radiation therapy will be reviewed

Intervention Type RADIATION

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Surgery Radiation Therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients must have at least one keloid lesion.
* Availability of photographic documentation of keloid lesion(s).

Exclusion Criteria

* Lack of photographic documentation of keloid lesion(s)
* Lack of demographic data
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tirgan, Michael H., M.D.

INDIV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael H Tirgan, MD

Role: STUDY_CHAIR

Keloid Research Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Michael H. Tirgan MD

New York, New York, United States

Site Status RECRUITING

Texas Institute of Dermatology

San Antonio, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael H Tirgan, MD

Role: CONTACT

212 874 4200

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michael H Tirgan, MD

Role: primary

212-874-4200

Reza Ghohestani, MD, PhD

Role: primary

210-698-6777

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Tirgan 16-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.